Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2025
First experience from 200 cases with a new breast tissue expander for multi-stage pre-pectoral breast reconstruction after mastectomy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Limido E, Bonomi F, Guggenheim L, Peradze N, Parodi C, Schmauss D, Weinzierl A, Harder Y
Аннотация
BACKGROUND: Breast cancer is the most common cancer globally, and mastectomy rates are increasing. Tissue expander-based breast reconstruction is used when direct-to-implant methods are unsuitable. A novel magnetic resonance imaging compatible breast tissue expander has recently been introduced. This study aims to evaluate its clinical use in pre-pectoral breast reconstruction and its complication profile.
METHODS: A monocentric prospective cohort study included women undergoing expander-based breast reconstruction after mastectomy with the new tissue expander between August 2020 and October 2024. The expanders were placed in a pre-pectoral plane with optional use of acellular dermal matrices in selected cases. Demographic data, comorbidities, and surgical details were analyzed. Tissue expander-independent and -dependent complications were assessed.
RESULTS: A total of 200 tissue expanders were implanted in 146 patients (92 unilateral, 54 bilateral). Major complications requiring expander replacement included infection (3.0%), partial necrosis of the mastectomy flap (2.5%), wound dehiscence (1.0%), hematoma (1.0%), and seroma (0.5%). Tissue expander rotation and/or flipping, as well as iatrogenic rupture, occurred in 2% and 3.5% of all cases. Definitive removal was required in ten cases, mainly due to mastectomy flap necrosis and wound dehiscence with or without expander exposure (2.5%), as well as infection (2.0%).
DISCUSSION: The new breast tissue expander features a biocompatible surface that does not adhere to adjacent tissues and therefore needs fixation alongside the inframammary fold, particularly if used in the pre-pectoral plane, contributing to a low complication rate. While short-term results are promising, long-term follow-up on a larger scale is needed to confirm these outcomes.
METHODS: A monocentric prospective cohort study included women undergoing expander-based breast reconstruction after mastectomy with the new tissue expander between August 2020 and October 2024. The expanders were placed in a pre-pectoral plane with optional use of acellular dermal matrices in selected cases. Demographic data, comorbidities, and surgical details were analyzed. Tissue expander-independent and -dependent complications were assessed.
RESULTS: A total of 200 tissue expanders were implanted in 146 patients (92 unilateral, 54 bilateral). Major complications requiring expander replacement included infection (3.0%), partial necrosis of the mastectomy flap (2.5%), wound dehiscence (1.0%), hematoma (1.0%), and seroma (0.5%). Tissue expander rotation and/or flipping, as well as iatrogenic rupture, occurred in 2% and 3.5% of all cases. Definitive removal was required in ten cases, mainly due to mastectomy flap necrosis and wound dehiscence with or without expander exposure (2.5%), as well as infection (2.0%).
DISCUSSION: The new breast tissue expander features a biocompatible surface that does not adhere to adjacent tissues and therefore needs fixation alongside the inframammary fold, particularly if used in the pre-pectoral plane, contributing to a low complication rate. While short-term results are promising, long-term follow-up on a larger scale is needed to confirm these outcomes.